Irvine Pharmaceutical Services is incorporating its Avrio parenteral manufacturing facility into the Irvine brand as part of an effort to better align its service portfolio and streamline processes for clients.   The custom-built parenteral manufacturing facility includes three cGMP manufacturing suites, and a formulation lab and pilot suite. Features include passive restrictive access barrier system (RABS) for filling, dedicated air-handling in each suite, and video surveillance to view product...